Swiss an­ti­body shop Num­ab strikes an im­muno-on­col­o­gy dis­cov­ery deal with Japan’s Ono

Al­most ex­act­ly two years af­ter Intar­cia turned to the Swiss an­ti­body shop Num­ab Ther­a­peu­tics for a sta­ble mul­ti­spe­cif­ic an­ti­body that would fit in­to a once …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.